| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
9 |
| issn |
1178-203X |
| pageRange |
173-9 |
| publicationName |
Therapeutics and Clinical Risk Management |
| startingPage |
173 |
| bibliographicCitation |
Charlton R. Optimal management of giant cell arteritis and polymyalgia rheumatica. Ther Clin Risk Manag. 2012;8():173–9. PMID: 22547936; PMCID: PMC3333461. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c611054cee752528d07e10de47d84616 |
| date |
201204 |
| identifier |
https://doi.org/10.2147/tcrm.s13088
https://pubmed.ncbi.nlm.nih.gov/PMC3333461
https://pubmed.ncbi.nlm.nih.gov/22547936 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33049
https://portal.issn.org/resource/ISSN/1178-203X |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Optimal management of giant cell arteritis and polymyalgia rheumatica |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7062
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 |